Related Experiment Video
Updated: Apr 15, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans
Hsiu-Jung Lo1, Kuo-Yun Tseng2, Yeong-Yi Kao3
1National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan; School of Dentistry, China Medical University, Taichung, Taiwan.
Abstract:
The cph1/cph1 efg1/efg1 double mutant in Candida albicans is defective in filamentous growth and is avirulent in a mouse model. We previously reported that Efg1p but not Cph1p is involved in drug resistance by negatively regulating ERG3 in C. albicans. In the current study, we have found that overexpression of CPH1 in Saccharomyces cerevisiae increases susceptibility to the antifungal drug fluconazole. Furthermore, in C. albicans, null mutation of CPH1 increased the expression of MDR1 as well as decreased susceptibility to fluconazole and voriconazole but not to amphotericin B. These findings indicate that although Efg1p and Cph1p may have the same effects on virulence, they have opposite effects on drug resistance in C. albicans.
Insights
Candida albicans transcription factors Efg1p and Cph1p have opposing roles in antifungal drug resistance. Cph1p enhances susceptibility to fluconazole, while Efg1p confers resistance.
Area of Science:
- Mycology
- Molecular Biology
- Antifungal Drug Resistance
Background:
- The transcription factor Efg1p in Candida albicans is implicated in virulence and negatively regulates ERG3, affecting drug resistance.
- Cph1p, another transcription factor, has been studied in conjunction with Efg1p regarding filamentous growth and virulence.
Purpose of the Study:
- To investigate the distinct roles of Cph1p and Efg1p in Candida albicans drug resistance.
- To determine the effect of CPH1 overexpression and mutation on susceptibility to antifungal agents.
Main Methods:
- Gene manipulation (overexpression and null mutation) of CPH1 in Saccharomyces cerevisiae and Candida albicans.
- Assessment of antifungal susceptibility to fluconazole, voriconazole, and amphotericin B.
- Gene expression analysis, including MDR1.
Main Results:
- Overexpression of CPH1 in Saccharomyces cerevisiae led to increased susceptibility to fluconazole.
- In Candida albicans, a null mutation of CPH1 resulted in increased MDR1 expression.
- The cph1 null mutant exhibited decreased susceptibility to fluconazole and voriconazole, but not amphotericin B.
Conclusions:
- Efg1p and Cph1p exhibit opposing effects on drug resistance in Candida albicans, despite potentially similar roles in virulence.
- Cph1p appears to play a role in increasing susceptibility to certain antifungal drugs, contrasting with Efg1p's role in resistance.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Antifungal Agents
Gene Regulation in Microbial Communities: Quorum Sensing

